1. Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
   Hui Cheng et al, 2023, BMC Gastroenterology CrossRef
2. Small interfering RNA targeting N‑cadherin regulates cell proliferation and migration in enzalutamide‑resistant prostate cancer
   Cheng-Hsin Lu et al, 2022, Oncology Letters CrossRef
3. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity
   Elisa Lozano et al, 2023, Cells CrossRef
4. m6A methylation of RNF43 inhibits the progression of endometriosis through regulating oxidative phosphorylation via NDUFS1
   Yuxia Tang et al, 2024, Journal of Cellular Physiology CrossRef
5. Black rice bran‑derived anthocyanins attenuate cholangiocarcinoma cell migration via the alteration of epithelial‑mesenchymal transition and sialylation
   Sasikamon Khophai et al, 2024, Biomedical Reports CrossRef
6. Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
   Aussara Panya et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. The RSPO‐LGR4/5‐ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease
   Stefano Annunziato et al, 2022, Hepatology CrossRef
8. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
   Jose Marin et al, 2022, Cancers CrossRef